Hybrid argon pasma coagulation-assisted mucosal ablation in the management of refractory gastroesophageal reflux disease
Endoscopy · 01.12.2024 · 56 (S 01 S 01) · E63-E64
DOI: 10.1055/a-2229-4443 ↗Kurz gefasst
Fallbericht in der Zeitschrift Endoscopy, erschienen am 01.12.2024. Verfasst von Yun Bao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, South China Hospital, Medical School, Shenzhen University, Shenzhen, China. Hauptthemen laut MEDLINE: Argon, Gastroesophageal Reflux. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, South China Hospital, Medical School, Shenzhen University, Shenzhen, China.
- Department of Gastroenterology, Southern Medical University, Nanfang Hospital, Guangzhou, China.
Zitieren
APA
Bao, Y., Huang, S., Qiu, Q., Liao, S., Hong, X., He, M., & Qiao, W. (2024). Hybrid argon pasma coagulation-assisted mucosal ablation in the management of refractory gastroesophageal reflux disease. Endoscopy, 56(S 01 S 01), E63-E64. https://doi.org/10.1055/a-2229-4443
Vancouver
Bao Y, Huang S, Qiu Q, Liao S, Hong X, He M, et al. Hybrid argon pasma coagulation-assisted mucosal ablation in the management of refractory gastroesophageal reflux disease. Endoscopy. 2024;56(S 01 S 01):E63-E64. doi:10.1055/a-2229-4443
BibTeX
@article{Bao2024,
author = {Bao, Yun and Huang, Silin and Qiu, Qiuping and Liao, Suhuan and Hong, Xiaoping and He, Miao and Qiao, Weiguang},
title = {Hybrid argon pasma coagulation-assisted mucosal ablation in the management of refractory gastroesophageal reflux disease},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 01 S 01},
pages = {E63--E64},
doi = {10.1055/a-2229-4443}
}
EUVIMED